Georgina M. Tiller

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

The use of JAK inhibitors and tocilizumab in the management of TRAPS: a sibling case study.

The use of JAK inhibitors and tocilizumab in the management of TRAPS: a sibling case study.

Journal: Pediatric rheumatology online journal

Published: February 04, 2026

Investigating the Impact of Juvenile Idiopathic Arthritis on Health, Costs, and Quality of Life in Australia: The IMPACT Study.

Investigating the Impact of Juvenile Idiopathic Arthritis on Health, Costs, and Quality of Life in Australia: The IMPACT Study.

Journal: The Journal of pediatrics

Published: December 18, 2025

Clinical characteristics and outcomes of paediatric CNO: a retrospective cohort study with focus on zoledronic acid.

Clinical characteristics and outcomes of paediatric CNO: a retrospective cohort study with focus on zoledronic acid.

Journal: Rheumatology (Oxford, England)

Published: December 12, 2025

Validation of Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis.

Validation of Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis.

Journal: Arthritis care & research

Published: November 20, 2025

Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review.

Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review.

Journal: Paediatric drugs

Published: July 28, 2025

Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.

Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.

Journal: Annals of the rheumatic diseases

Published: March 07, 2025

Disease modifying anti-rheumatic drug treatment cycles and rates of flare in juvenile idiopathic arthritis-a tale of Sisyphean endeavour?

Disease modifying anti-rheumatic drug treatment cycles and rates of flare in juvenile idiopathic arthritis-a tale of Sisyphean endeavour?

Journal: Rheumatology (Oxford, England)

Published: February 23, 2025

Enrolment of the first paediatric cohort into the Australian lupus registry and biobank: A single-centre experience.

Enrolment of the first paediatric cohort into the Australian lupus registry and biobank: A single-centre experience.

Journal: Lupus

Published: April 08, 2024

Methotrexate for juvenile idiopathic arthritis.

Methotrexate for juvenile idiopathic arthritis.

Journal: The Cochrane database of systematic reviews

Published: February 09, 2024

Deficiency of adenosine deaminase 2 (DADA2) presenting with diffuse skeletal muscle vasculitis.

Deficiency of adenosine deaminase 2 (DADA2) presenting with diffuse skeletal muscle vasculitis.

Journal: Journal of paediatrics and child health

Published: September 01, 2023

Three- and five-year outcomes of an inception cohort of Australian children with juvenile idiopathic arthritis.

Three- and five-year outcomes of an inception cohort of Australian children with juvenile idiopathic arthritis.

Journal: International journal of rheumatic diseases

Published: July 27, 2023

Reassuring short-term effect of corticosteroids for Kawasaki disease.

Reassuring short-term effect of corticosteroids for Kawasaki disease.

Journal: Journal of paediatrics and child health

Published: November 15, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026